Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Oppenheimer Holdings (OPY) Research & Development (2016 - 2025)

Oppenheimer Holdings (OPY) has disclosed Research & Development for 16 consecutive years, with $27.4 million as the latest value for Q4 2025.

  • Quarterly Research & Development rose 7.63% to $27.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $105.8 million through Dec 2025, up 6.45% year-over-year, with the annual reading at $105.8 million for FY2025, 6.45% up from the prior year.
  • Research & Development hit $27.4 million in Q4 2025 for Oppenheimer Holdings, up from $25.9 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $27.4 million in Q4 2025 to a low of $19.2 million in Q2 2021.
  • Historically, Research & Development has averaged $23.1 million across 5 years, with a median of $22.7 million in 2023.
  • Biggest five-year swings in Research & Development: fell 10.09% in 2021 and later rose 9.52% in 2024.
  • Year by year, Research & Development stood at $21.0 million in 2021, then increased by 2.24% to $21.5 million in 2022, then rose by 9.38% to $23.5 million in 2023, then grew by 8.48% to $25.5 million in 2024, then rose by 7.63% to $27.4 million in 2025.
  • Business Quant data shows Research & Development for OPY at $27.4 million in Q4 2025, $25.9 million in Q3 2025, and $26.2 million in Q2 2025.